Evidence map›Paper›PMID 34056293›Full record

ArticleACS omega2021

Synthesis and Anti-Pancreatic Cancer Activity Studies of Novel 3-Amino-2-hydroxybenzofused 2-Phospha-γ-lactones.

Satheesh Krishna Balam, Jayaprakash Soora Harinath, Suresh Kumar Krishnammagari, Raghavendra Reddy Gajjala, Kishore Polireddy, Vijaya Bhaskar Baki, Wei Gu, Koteswara Rao Valasani, Vijaya Kumar Reddy Avula, Swetha Vallela and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 6 countries.

Satheesh Krishna BalamDepartment of Chemistry, Sri Venkateswara University, Tirupati 517 502, India.
Jayaprakash Soora HarinathDepartment of Chemistry, Sri Venkateswara University, Tirupati 517 502, India.
Suresh Kumar KrishnammagariDepartment of Chemistry, Sri Venkateswara University, Tirupati 517 502, India.
Raghavendra Reddy GajjalaDepartment of Chemistry, Sri Venkateswara University, Tirupati 517 502, India.
Kishore PolireddyDivision of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas 77030, United States.
Vijaya Bhaskar BakiDepartment of Pathophysiology, The Key Immunopathology Laboratory of Guangdong Province, Shantou University Medical College, Shantou 515031, Guangdong Province, China.
Wei GuDepartment of Pathophysiology, The Key Immunopathology Laboratory of Guangdong Province, Shantou University Medical College, Shantou 515031, Guangdong Province, China.
Koteswara Rao ValasaniDepartment of Pharmacology & Toxicology and Higuchi Bioscience Center, School of Pharmacy, University of Kansas, Lawrence, Kansas 66047, United States.
Vijaya Kumar Reddy AvulaChemical Engineering Institute, Ural Federal University, Yekaterinburg 620002, Russian Federation.
Swetha VallelaChemical Engineering Institute, Ural Federal University, Yekaterinburg 620002, Russian Federation.
Grigory Vasilievich ZyryanovChemical Engineering Institute, Ural Federal University, Yekaterinburg 620002, Russian Federation.
Visweswara Rao PasupuletiDepartment of Biomedical Sciences and Therapeutics, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, Malaysia.
Suresh Reddy CirandurDepartment of Chemistry, Sri Venkateswara University, Tirupati 517 502, India.ORCID 0000-0002-9804-9683
Sri Venkateswara University · INUral Federal University · RUShantou University · CNThe University of Texas Health Science Center at Houston · USUniversiti of Malaysia Sabah · MYUniversity of Kansas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of 3-amino-2-hydroxybenzofused 2-phosphalactones (

Identifiers

PMID34056293
PMCPMC8153908
OpenAlexW3159636527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.